演讲题目:

讲者:

讲者背景: 

Professor Alberto Zanchetti is Professor Emeritus of Internal Medicine at the University of Milan and Scientific Director of the Istituto Auxologico Italiano. At present, he is the coordinator of a Network of Excellence InGenious HyperCare, with a grant from the European Commission.

Professor Zanchetti has been President of the European Society of Clinical Investigation, the European Society of Hypertension, the International Society of Hypertension, the Working Group on Hypertension and the Heart of the European Society of Cardiology, the Società Italiana dell'Ipertensione Arteriosa. He has been member of the Hypertension Guidelines Committee of the WHO and ISH since its inception, and member of the Task Force for the ESH and ESC guidelines on the management of hypertension. Since 1995 he is Editor-in-Chief of the Journal of Hypertension. He has received a number of awards (International Achievement Award, American Heart Association; Franz Volhard Award, International Society of Hypertension; International Lecture, British Cardiac Society; Riva-Rocci Award, Società Italiana Ipertensione Arteriosa). He is Honorary Member of the European Society of Hypertension, the Australian High Blood Pressure Research Council, the Council of Clinical Cardiology of the American Heart Association, the Spanish, Swedish, German, Hungarian, Polish, Ukrainan, Greek, Venezuelan, Peruvian, Latin American Societies of Hypertension. He is Member of the Académie Royal de Médecine de Belgique, Corresponding Member of the German Society of Internal Medicine. Honorary Professor of the Catholic University of Chile; Honorary Degree in Medicine, University of Guadalajara.

Professor Zanchetti has published over 800 articles, books and volume chapters, which have received over 17000 citations in the medical literature.

演讲题目:

讲者:

讲者背景: 

Haralambos Gavras is Professor of Medicine at Boston University School of Medicine and Chief the Hypertension and Atherosclerosis Section at Boston Medical Center in Boston, Massachusetts, USA. He has been the Director of an NIH-supported Specialized Center of Research in the Molecular Genetics of Hypertension and a member of various NIH Study Sections and Advisory Committees.

Dr. Gavras obtained his medical degree from Athens University School of Medicine in Athens, Greece, and his postgraduate training at the Western Infirmary, Glasgow, Scotland, UK, as a British Council Scholar.

pioneer in the research of the renin-angiotensin system, he was the first to introduce ACE inhibition and angiotensin II blockade for the treatment of patients with hypertension, congestive heart failure, or both. Dr. Gavras has received the Novartis Award from the Council of High Blood Pressure Research of the American Heart Association in 2000 and the Franz Volhard Award International Society of Hypertension in 2004, as well as numerous other awards and Honorary Doctorates. He is a Fellow of the Royal College of Physicians, (Glasgow), past President of the American Society of Hypertension and the Inter-American Society of Hypertension and past Chairman of the Hypertension Council of the American Heart Association. He has been on the faculty of Boston University since 1975 and is the author of more than 645 publications.

演讲题目:

讲者:

讲者背景: 

Dr. Alderman is a Fellow of the American College of Physicians and a member of the Association of American Physicians. He was the Chairman of the Department of Epidemiology and Social Medicine at Albert Einstein College of Medicine. He remains Professor Epidemiology and Population Health and Medicine, and Professor and Associate Director of the Cardiovascular Center at the New York Hospital-Cornell University Medical College. Dr. Alderman served as President of the American Society of Hypertension, 1996-98 and is immediate Past President (2004-06) of the International Society of Hypertension.

Dr. Alderman has authored more than 250 scientific papers, book chapters and textbooks. His best-known work in this regard relates the renin/angiotensin system and sodium intake to cardiovascular disease.

演讲题目:

讲者:

讲者背景: 

Dr Peter Meredith is currently Reader in Clinical Pharmacology in the Department of Medicine and Therapeutics of the University of Glasgow and was Director of Research and Development in the West Glasgow Hospitals University NHS Trust from 1997 to 2000.

His publication list includes over 300 peer reviewed papers in leading international journals predominantly in hypertension and clinical pharmacology. He is a former executive editor of the British Journal of Clinical Pharmacology and serves on the editorial boards of the Journal of Hypertension, Blood Pressure and Annals of Experimental and Clinical Medicine. He was member of the Scientific Committee of the European Society of Cardiology from 1995-1999.

演讲题目:

讲者:

讲者背景: 

Dr. Peter M Nilsson is currently Professor of Clinical Cardiovascular Research at the Department of Clinical Sciences, Lund University, Sweden. For many years Dr. Nilsson has been an active member of the European Society of Hypertension and chairman of the European Society of Hypertension (ESH) Working Group “Hypertension in Diabetes”. Since 2006 he has been elected to be a member of the ESH Council, responsible for the web page (www.eshonline.org). Dr. Nilsson is also involved in quality assessment of diabetes care as a member of the data group for the National Diabetes Register of Sweden. He has published more than 180 papers in peer-reviewed medical journals.

演讲题目:

讲者:

讲者背景: 

Peter Sleight is Honorary Consultant at the John Radcliffe Hospital, Oxford. Professor Sleight was Chair of the ISIS Trials Group Steering Committee and the related coronary prevention studies co-ordinated from the Clinical Trials Service Unit in Oxford.

He was Chairman, International Agency on Tobacco and Health 1991 - 1993, Vice-President 1993- World Hypertension League, President 1995-2000, 1993- 95 President, British Hypertension Society.

He was awarded the Galen Medal by the Society of Apothecaries in recognition of his work in circulatory physiology and clinical trials. With Colin Baigent, Rory Collins and Richard Peto, he received the International Aspirin Foundation Senior Award for 2000. He has also been awarded: the Mackenzie Medal of the British Cardiac Society in 2003; the Alberto Zanchetti lifetime achievement award of the European Society of Hypertension in 2005; and the Outstanding Research Award of the Russian Federation Society of Cardiology, 2005. In 2008 he was International Lecturer, American College of Cardiology.

演讲题目:

讲者:

讲者背景: 

Since 1995 Stephen Harrap has been Professor in the Department of Physiology at the University of Melbourne. He is also a visiting specialist physician at the Royal Melbourne Hospital. He has long-standing research interests in the genetics of common conditions, in particular cardiovascular disease. As Director of the Victorian Family Heart Study and the AMIGO Study he has been instrumental in important discoveries of the genetics of blood pressure, acute coronary syndrome, height and male pattern baldness. He was the Regional Principal Investigator and Member of the International Management Committee for the PROGRESS and ADVANCE Studies of secondary stroke prevention and cardiovascular protection in diabetes respectively. He is on a range of professional committees, editorial boards and advisory groups. Currently he is the President of the High Blood Pressure Research Council of Australia and President-Elect of the International Society of Hypertension.

照片

演讲题目:

讲者:

讲者背景: 

Doctor Sylvie Stachenko is a Public Health expert in the field of health promotion and chronic disease prevention with over 20 years of experience in academic, community and government organizations at international, national and local levels. She has led chronic disease policies at national level in Canada including cancer control, diabetes, cardiovascular, breast cancer, AIDS.

Doctor Stachenko is the first Dean of the School of Public Health at the University of Alberta..Prior to 2009 ,Dr. Sylvie Stachenko was the Deputy Chief Public Health Officer at the Public Health Agency of Canada .From 2002-2004 she was the Director General in the Centre for Chronic Disease Prevention and Control at Health Canada and from 1997 to 2002, Dr. Stachenko had been working with the World Health Organization (WHO) Regional Office for Europe located in Copenhagen, Denmark as their Director of Health Policy and Services.

Dr. Stachenko earned a Doctorate in Medicine from McGill University She finished her residency in family medicine at the Université de Montréal and she earned a Master’s degree in Epidemiology and Health Services Administration from the Harvard School of Public Health in 1985.

照片

演讲题目:

讲者:

讲者背景: 

Qing Wang
PhD. Director
Center For Cardiovascular Genetics
Switzerland

照片

演讲题目:

讲者:

讲者背景: 

Stevo Julius
Professor,MD, ScD
University of Michigan Cardiovascular Center
USA